126 Results for "

SOS

" in MedChemExpress (MCE) Product Catalog:
Products (126)

126 Results for "SOS" in MCE Product Catalog:

  • Targets Recommended:
58
58 Publications Verification
Cat. No.: HY-134813
CAS No.: 2621928-55-8
Purity:  99.97%
Target:  

Ras

Research Areas:  

Cancer

MRTX1133 is a noncovalent, potent, and selective alkyne-based KRAS G12D inhibitor. MRTX1133 optimally fills the switch II pocket and extends three substituents to favorably interact with the protein, resulting in an estimated KD against KRAS G12D of 0.2 pM. MRTX1133 prevents SOS1-catalyzed nucleotide exchange and/or formation of the KRAS G12D/GTP/RAF1 complex, thereby inhibiting mutant KRAS-dependent signal transduction. MRTX1133 selectively inhibits KRAS G12D mutant, but not KRAS wild-type, tumor cells. MRTX1133 has single digit nanomolar activity in cellular assays and marked in vivo efficacy in tumor models harboring KRAS G12D mutations .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-125817
CAS No.: 2230836-55-0
Purity:  99.95%
Target:  

SOS1 Ras p38 MAPK

Research Areas:  

Cancer

BI-3406 (compound I-6) is an orally active, highly potent and selective inhibitor of the interaction between KRAS and Son of Sevenless 1 (SOS1) with an IC50 of 6 nM. BI-3406 potently reduces the formation of GTP-loaded KRAS, and inhibits MAPK pathway signaling. BI-3406 has anticancer activity .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-145928
CAS No.: 2417987-45-0
Purity:  99.31%
Synonyms: GDC-6036
Target:  

Ras

Research Areas:  

Cancer

Divarasib (GDC-6036) is an orally active, selective KRAS G12C inhibitor with an IC50 of <0.01 μM. Divarasib covalently binds Cys12 in GDP-bound KRAS G12C, occupies the switch II pocket, blocks GTP binding and SOS-mediated reactivation, and inhibits oncogenic KRAS signaling. Divarasib induces tumor shrinkage and robust tumor growth inhibition in KRAS G12C-positive models and cancer cells. Divarasib can be used for the research of non-small cell lung cancer, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, and other KRAS G12C-mutated solid tumors .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-145928B
CAS No.: 2762240-36-6
Synonyms: GDC-6036 adipate
Target:  

Ras

Research Areas:  

Cancer

Divarasib (GDC-6036) adipate is an orally active, selective KRASG12C inhibitor with an IC50 of <0.01 μM. Divarasib adipate covalently binds Cys12 in GDP-bound KRASG12C, occupies the switch II pocket, blocks GTP binding and SOS-mediated reactivation, and inhibits oncogenic KRAS signaling. Divarasib adipate induces tumor shrinkage and robust tumor growth inhibition in KRASG12C-positive models and cancer cells. Divarasib adipate can be used for the research of non-small cell lung cancer, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, and other KRASG12C-mutated solid tumors .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114398
CAS No.: 2244904-70-7
Purity:  98.97%
Target:  

SOS1 Ras

Research Areas:  

Cancer

BAY-293, a valuable chemical probe, blocks RAS activation via disruption of the KRAS-SOS1 interaction with an IC50 of 21 nM. BAY-293 is a potent inhibitor of Son of Sevenless 1 (SOS1). SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145926
CAS No.: 2654743-22-1
Purity:  99.75%
Target:  

SOS1 Ras

Research Areas:  

Neurological Disease Cancer

MRTX0902 is a potent, selective, brain-penetrant, and orally active SOS1 inhibitor with a Ki of 1.9 nM. MRTX0902 disrupts the SOS1:KRASG12C protein-protein interaction (PPI). MRTX0902 can be used in research on pancreatic ductal adenocarcinoma .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-132966
CAS No.: 2241719-73-1
Purity:  98.28%
Target:  

Ras ERK

Research Areas:  

Cancer

ASP2453 is a potent, selective and orally active KRAS G12C inhibitor. ASP2453 inhibits the Son of Sevenless (SOS)-mediated interaction between KRAS G12C and Raf with an IC50 value of 40 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-134885
CAS No.: 2488788-52-7
Purity:  98.96%
Synonyms: RM-023
Target:  

SHP2 SOS1 Ras

Research Areas:  

Cancer

RMC-0331 (RM-023) is a potent, selective and orally bioavailable SOS1 inhibitor. RMC-0331 is an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-138616
CAS No.: 2564-35-4
Synonyms: 2'-Deoxyguanosine-5'-triphosphate
dGTP (2'-Deoxyguanosine-5'-triphosphate) is one of the precursors for DNA synthesis, and serves as a direct substrate for DNA replication and repair. dGTP is prone to oxidative damage; under the action of reactive oxygen species and other factors, dGTP is oxidized to form 8-oxo-dGTP .
loading...
    loading...
Defibrotide sodium
0 Images
Defibrotide (sodium)
Cat. No.: HY-108746
CAS No.: 83712-60-1
Defibrotide sodium is a complex mixture of single stranded polydeoxyribonucleotides. Defibrotide sodium has liver protection, anti-inflammatory, antithrombotic, profibrinolytic, and anti-ischemic properties. Defibrotide sodium can be used for sinusoidal obstruction syndrome (SOS)/veno-occlusive disease (VOD) research .
loading...
    loading...
Cat. No.: HY-151881
CAS No.: 2793404-47-2
Purity:  99.51%
Target:  

SOS1 Ras

Research Areas:  

Cancer

SOS1-IN-15 (Compound 37) is an orally active SOS1 inhibitor with an IC50 of 5 nM. SOS1-IN-15 is a promising agent candidate for the research of KRAS-driven cancer .
loading...
    loading...
Cat. No.: HY-111671
CAS No.: 2245237-53-8
Purity:  98.01%
Synonyms: SOS1 activator 1
Research Areas:  

Cancer

VUBI1 (SOS1 activator 1) is a benzimidazole derivative and SOS1 activator with a Kd of 44 nM. VUBI1 can significantly activate RAS-GTP and regulate the phosphorylation of ERK. VUBI1 also can serve as a target ligand for synthesizing PROTACs, such as PROTAC SOS1 degrader-1 (HY-145737), to induce SOS1 degradation. VUBI1 can be used in the study of cancer .
loading...
    loading...
Cat. No.: HY-18674
CAS No.: 84783-01-7
Target:  

Ras

Research Areas:  

Cancer

K-Ras-IN-1 is the inhibitor for K-Ras by occupying the binding site of son of sevenless (Sos), preventing the interaction between Sos and K-Ras, inhibiting the Sos-catalyzed GDP to GTP exchange process. K-Ras-IN-1 is promising for research of pancreatic, colon and lung cancer .
loading...
    loading...
Cat. No.: HY-114398A
CAS No.: 2244904-69-4
Target:  

Ras SOS1

Research Areas:  

Others

(S)-BAY-293 is a negative control of BAY 293. BAY 293 is a potent KRAS-SOS1 interaction inhibitor .
loading...
    loading...
Cat. No.: HY-P2265A
CAS No.: 2896737-31-6
Target:  

SOS1 Ras

Research Areas:  

Cancer

SAH-SOS1A TFA is a peptide-based SOS1/KRAS protein interaction inhibitor. SAH-SOS1A TFA binds to wild-type and mutant KRAS (G12D, G12V, G12C, G12S, and Q61H) with nanomolar affinity (EC50=106-175 nM). SAH-SOS1A TFA directly and independently blocks nucleotide association. SAH-SOS1A TFA impairs KRAS-driven cancer cell viability and exerts its effects by on-mechanism blockade of the ERK-MAPK phosphosignaling cascade downstream of KRAS .
loading...
    loading...
Cat. No.: HY-U00035
CAS No.: 1000277-08-6
Research Areas:  

Infection

MGB-BP-3 is an orally aective Gram-positive bactericide and DNA-binding agent. MGB-BP-3 blocks transcription initiation by binding to AT-rich bacterial DNA regions, and interferes with the functions of DNA gyrase and topoisomerase IV, but does not stabilize cleavage complexes or induce the SOS response. MGB-BP-3 induces energy depletion in *Staphylococcus aureus* and inhibits spore formation in *Clostridioides difficile*, exhibiting intrinsic resistance resilience. MGB-BP-3 can be used in the research of *Clostridioides difficile*-associated diseases .
loading...
    loading...
Cat. No.: HY-145737A
Purity:  99.38%
Target:  

Ras PROTACs SOS1

Research Areas:  

Cancer

PROTAC SOS1 degrader-1 (TFA) is a potent PROTAC SOS1 degrader with an DC50 of 98.4 nM. PROTAC SOS1 degrader-1 shows antiproliferation activity in cancer cells with various KRAS mutations. PROTAC SOS1 degrader-1 shows antitumor effect with low toxicity .
loading...
    loading...
Cat. No.: HY-W096997A
CAS No.: 142-31-4
Synonyms: Sodium capryl sulfate, 95%
Sodium octyl sulfate (SOS), 95% (Sodium capryl sulfate, 95%) is an anionic detergent and ion-pairing agent.
loading...
    loading...
Cat. No.: HY-153606
CAS No.: 2245237-61-8
Purity:  97.24%
Target:  

Drug Derivative HDAC

Research Areas:  

Cancer

VUBI1 analogue-1 (compound 79) is a VUBI1 (HY-111671) analogue. VUBI1 (SOS1 activator 1) is a SOS1 activator with a Kd of 44 nM. VUBI1 analogue-1 can be used to synthesize (4S)-PROTAC SOS1 degrader-1 (HY-144657) [1] .
loading...
    loading...
Cat. No.: HY-163939
CAS No.: 2794934-49-7
Target:  

SOS1 Ras

Research Areas:  

Cancer

RGT-018 is a potent and orally active SOS1 inhibitor with anti-tumor effects. RGT-018 exerts anti-cancer cell proliferation activity by inhibiting KRAS activation .
loading...
    loading...